Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 604
Selected: 0
NCT IDTitle
NCT07447635Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
NCT00948922Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
NCT03977402Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT04869137Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
NCT01434069Phase I Trial of Combination of FOLFIRI and SOM 230
NCT00504257Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
NCT03072043Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
NCT06305676Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
NCT03183050MEND 2: Making Treatment Decisions Using Genomic Testing
NCT06497569Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
NCT04760873Cryotherapy for GAVE
NCT03232411Biobank for African American Prostate Cancer Research in Florida
NCT05170334Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
NCT04191187Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT07276386Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
NCT02948946Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02243124A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
NCT01434550Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
NCT04980157CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
NCT01497496Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT05496686Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
NCT02989870Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
NCT02061007Biomarker Correlates of Hypoxia in Metastatic Melanoma
NCT02572284Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
NCT01754623GTX-RT in Borderline Resectable Pancreatic Cancer
NCT01927120In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis
NCT00313508Dendritic Cell Vaccination During Lymphoid Reconstruction
NCT04101526Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance
NCT01175291FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer
NCT06121180Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
NCT01324180Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
NCT06961357Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
NCT03758781IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
NCT05083416Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome
NCT00964743Depocyt® With Sorafenib in Neoplastic Meningitis
NCT05694364Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
NCT06734130Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
NCT05177211Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
NCT04091165Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
NCT00351039Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer
NCT02708381Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database
NCT05379933Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life
NCT00977548Erlotinib Study for Myelodysplastic Syndrome (MDS)
NCT06463184Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)
NCT05093608SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma
NCT02796391Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
NCT02403310A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
NCT00215956A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
NCT03078348Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks